BioStock: Aptahem's founder is back – now as Chairman of the Board

On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a founder of several companies in the industry, including Aptahem in 2014, Junno brings extensive experience from business development, drug development and fund raising in the resource-intensive industry. In order to finance the continued development towards clinical studies, Aptahem is currently raising just over 32 MSEK in a rights issue of units. BioStock reached out to Junno who shared his visions for the company. 

Read the full interview with Bert Junno at biostock.se:

https://www.biostock.se/en/aptahems-founder-is-back-now-as-chairman-of-the-board/

This is a pressrelease from BioStock - Connecting Innovation & Capital. https://www.biostock.se/